膀胱癌检测套件的全球市场:现状分析与预测(2022年～2028年)

全球膀胱癌检测套件的市场规模，在预测期间内预计以约11％的年复合成长率成长。膀胱癌的发生率增加，癌症与其治疗方法相关认识度的提高，医疗费的支出增加，抽烟、香烟消费的扩大，促进市场成长。

本报告提供全球膀胱癌检测套件市场的相关调查，市场洞察，市场趋势，竞争模式，企业概要等全面性资讯。

目录

第1章 市场简介

• 市场定义
• 主要目的
• 相关利益者
• 限制

第2章 调查方法或假设

• 膀胱癌检测套件市场调查流程
• 膀胱癌检测套件市场调查手法
• 受访者简介

第3章 市场摘要

第4章 摘要整理

第5章 COVID-19对膀胱癌检测套件市场的影响

第6章 膀胱癌检测套件的市场收益(10亿美元)(2022年～2028年)

第7章 市场洞察:各技术

• 萤光原位杂合反应(FISH)
• 酵素免疫分析法(ELISA)
• 其他

第8章 市场洞察:各类型

• 血液样品检验
• 尿样品检验
• 细胞样品检验

第9章 市场洞察:各终端用户

• 医院和诊所
• 诊断中心
• 居家医疗
• 研究中心
• 其他

第10章 市场洞察:各地区

• 北美
  • 美国
  • 加拿大
  • 其他北美
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 全球其他地区

第11章 膀胱癌检测套件的市场动态

• 推动市场要素
• 市场课题
• 影响分析

第12章 膀胱癌检测套件的市场机会

第13章 膀胱癌检测套件的市场趋势

第14章 需求面和供给方面的分析

• 需求面分析
• 供给面

第15章 价值链分析

第16章 竞争模式

• 竞争情形
  • 波特的五力分析

第17章 企业概要

• Cepheid
• BIOSYNEX SA
• Abbott Laboratories
• EXACT Sciences Corporation
• Abingdon Health PLC
• Xiamen Biotime Biotechnology Co., Ltd.
• IDL Biotech AB
• Alfa Scientific Designs
• Biomerica Inc
• Hologic Inc.

第18章 免责声明

Global Bladder Cancer Detection Kit Market is expected to grow at a significant rate of around 11% during the forecast period. This is mainly due to the increasing incidence of bladder cancer, increase in awareness about cancer and its available therapies, growing healthcare expenditure, and expanding smoking and tobacco consumption are anticipated to accelerate the market of the bladder cancer detection kit market. According to Globocan, the global burden of bladder cancer is significantly high, representing 3.0% of all new cancer diagnoses, 2.1% of all cancer deaths in 2020, and the 11thmost frequently diagnosed cancer worldwide. Hence, the government authorities are keenly observing the development of products related to bladder cancer detection kits. Furthermore, the growing focus of major players on different growth strategies such as research and development activities, and product approvals are further expected to increase the market. Thus, the growing focus and investment of key stakeholders in the research and development of technologically advanced bladder cancer detection kits is further expected to grow the market.

Cepheid, BIOSYNEX SA, Abbott Laboratories, EXACT Sciences Corporation, Abingdon Health PLC, Xiamen Biotime Biotechnology Co., Ltd., IDL Biotech AB, Alfa Scientific Designs, Biomerica Inc, Hologic Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

"Amongst technology, fluorescence in situ hybridization (FISH) category to witness significant CAGR during the forecast period"

Based on type, the market is segmented into fluorescence in situ hybridization (FISH), enzyme-linked immunosorbent assay (ELISA), and others. The fluorescence in situ hybridization (FISH) category witnessed a significant CAGR during the forecast period. This segment is expected to take the lead since it is a unique urine examination technology that uses fluorescent direct-tagged DNA probes to detect genetic abnormalities in urothelial cells detected in the urine.

"Amongst end user, the hospitals & clinics to hold a significant share in the market in 2020"

On the basis of end-user, the market is categorized into hospitals & clinics, diagnostic centre, home care, research centers, and others. Among these, the hospitals & clinics to hold a significant share in the market in 2020. The bladder cancer detection kit market in hospital infrastructure is being driven globally by innovations. Moreover, The investor building cancer detection and treatment hospitals are leveraging the bladder cancer market.

"North America to hold a significant share in the market"

In 2020, North America held a significant share of the global bladder cancer detection kit market. This is mainly attributed to the rising prevalence of bladder cancer across the region is driving the North American bladder cancer detection kit market. According to the American Cancer Society, about 83,730 new cases of bladder cancer and approximately 17,200 deaths from bladder cancer occurred in the US in 2020. Moreover, The development of the bladder cancer detection kit market in these regions is anticipated to be supported further by increased R&D investments, bettering healthcare infrastructure, and more government initiatives. As the prevalence and mortality rate is rising worldwide, the demand for bladder cancer diagnosis is increasing. This further increases the investment in R&D of non-invasive bladder cancer detection products, hence driving the bladder cancer detection kit market growth.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global bladder cancer detection kit market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Bladder Cancer Detection Kit Market
• 2.2. Research Methodology of the Bladder Cancer Detection Kit Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE BLADDER CANCER DETECTION KIT MARKET

6 BLADDER CANCER DETECTION KIT MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY TECHNOLOGY

• 7.1. Fluorescence In Situ Hybridization (FISH)
• 7.2. Enzyme-Linked Immunosorbent Assay (ELISA)
• 7.3. Others

8 MARKET INSIGHTS BY TYPE

• 8.1. Blood Sample Test
• 8.2. Urine Sample Test
• 8.3. Cell Sample Test

9 MARKET INSIGHTS BY END USER

• 9.1. Hospitals & Clinics
• 9.2. Diagnostic Centre
• 9.3. Home Care
• 9.4. Research centers
• 9.5. Others

10 MARKET INSIGHTS BY REGION

• 10.1. North America
  • 10.1.1. The U.S.
  • 10.1.2. Canada
  • 10.1.3. Rest of North America
• 10.2. Europe
  • 10.2.1. Germany
  • 10.2.2. The U.K.
  • 10.2.3. France
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. Asia-Pacific
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Rest of Asia-Pacific
• 10.4. Rest of World

11 BLADDER CANCER DETECTION KIT MARKET DYNAMICS

• 11.1. Market Drivers
• 11.2. Market Challenges
• 11.3. Impact Analysis

12 BLADDER CANCER DETECTION KIT MARKET OPPORTUNITIES

13 BLADDER CANCER DETECTION KIT MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

• 14.1. Demand Side Analysis
• 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

• 16.1. Competitive Landscape
  • 16.1.1. Porters Fiver Forces Analysis

17 COMPANY PROFILED

• 17.1. Cepheid
• 17.2. BIOSYNEX SA
• 17.3. Abbott Laboratories
• 17.4. EXACT Sciences Corporation
• 17.5. Abingdon Health PLC
• 17.6. Xiamen Biotime Biotechnology Co., Ltd.
• 17.7. IDL Biotech AB
• 17.8. Alfa Scientific Designs
• 17.9. Biomerica Inc
• 17.10. Hologic Inc.

18 DISCLAIMER